搜索筛选:
搜索耗时3.8650秒,为你在为你在102,285,761篇论文里面共找到 8 篇相符的论文内容
类      型:
[期刊论文] 作者:Zongzhe Li,Chengming Zhou,Lun, 来源:中国科学:生命科学英文版 年份:2017
Aortic dissection(AD) is a devastating,heterogeneous condition of aorta.The homeostasis between collagens and matrix metalloproteases(MMPs)/tissue inhibitors of...
[期刊论文] 作者:Zongzhe Li,Chengming Zhou,Lun, 来源:中国科学:生命科学英文版 年份:2018
Aortic dissection(AD)is a heterogeneous genetic disease of the aorta with high mortality and poor prognosis.However,only few genetic causes of AD have been expl...
[期刊论文] 作者:Junjie ZHENG,Zongzhe LI,Dongan ZHAO,Qiang MA,Rongjun ZHANG, 来源:中国高等学校学术文摘·建筑与土木工程 年份:2010
This paper deals with the floating resistance of super large caisson by numerical simulation, and the influence of air resistance on the caisson, which is often...
[期刊论文] 作者:Peng Chen,Zongzhe Li,Jiali Nie,Hong Wang,Bo Yu,Zheng Wen,Yang Sun,Xiaolu Shi,Li Jin,Dao-Wen Wang, 来源:中国科学:生命科学(英文版) 年份:2020
Hypertrophic cardiomyopathy (HCM) is a common genetic disease,predominantly caused by mutations in cardiac sarcomere genes;however,whether MYH7B causes HCM is n...
[期刊论文] 作者:Zongzhe Li,Chengming Zhou,Lun Tan,Peng Chen,Yanyan Cao,Chenze Li,Xianqing Li,Jiangtao Yan,Hesong Zeng, 来源:Science China(Life Sciences) 年份:2017
Aortic dissection(AD) is a devastating,heterogeneous condition of aorta.The homeostasis between collagens and matrix metalloproteases(MMPs)/tissue inhibitors of...
[期刊论文] 作者:Yanghui Chen,Yang Sun,Zongzhe Li,Chenze Li,Lei Xiao,Jiaqi Dai,Shiyang Li,Hao Liu,Dong Hu,Dongyang Wu,, 来源:医学前沿:英文版 年份:2021
Thoracic aortic dissection(TAD)without familial clustering or syndromic features is known as sporadic TAD(STAD).So far,the genetic basis of STAD remains unknown.Whole exome sequencing was performed in 223 STAD patients and 414 healthy contr......
[期刊论文] 作者:Yanghui Chen,Yang Sun,Zongzhe Li,Chenze Li,Lei Xiao,Jiaqi Dai,Shiyang Li,Hao Liu,Dong Hu,Dongyang Wu,, 来源:医学前沿 年份:2021
Thoracic aortic dissection (TAD) without familial clustering or syndromic features is known as sporadic TAD (STAD).So far,the genetic basis of STAD remains unkn...
[期刊论文] 作者:,Xiaowen Hu,Wei Tang,Haisheng Wang,Ling Zhou,Lujin Wu,Hong Wang,Chang Xu,Xizhen Xu,Zhichao Xiao,Zongzhe Li, 来源:医学前沿 年份:2021
We conducted a randomized,open-label,parallel-controlled,multicenter trial on the use of Shuanghuanglian(SHL),a traditional Chinese patent medicine,in treating cases of COVID-19.A total of 176 patients received SHL by three doses(56 in low ......
相关搜索: